
|Articles|January 30, 2016
Drug Approvals Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Catch up with the top news of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study
4
Delegating to Technicians: The Key to Pharmacists Practicing at Top of License
5




































































































